nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronabinol—CYP2A6—Ifosfamide—testicular cancer	0.119	0.134	CbGbCtD
Dronabinol—PTGS1—Ifosfamide—testicular cancer	0.102	0.115	CbGbCtD
Dronabinol—ABCG2—Dactinomycin—testicular cancer	0.0933	0.105	CbGbCtD
Dronabinol—ABCG2—Carboplatin—testicular cancer	0.0627	0.0707	CbGbCtD
Dronabinol—ABCG2—Cisplatin—testicular cancer	0.0536	0.0605	CbGbCtD
Dronabinol—ABCG2—Etoposide—testicular cancer	0.0527	0.0594	CbGbCtD
Dronabinol—CYP2C19—Ifosfamide—testicular cancer	0.0493	0.0555	CbGbCtD
Dronabinol—PTGS1—Etoposide—testicular cancer	0.0486	0.0548	CbGbCtD
Dronabinol—CYP2C9—Ifosfamide—testicular cancer	0.041	0.0462	CbGbCtD
Dronabinol—ABCG2—Doxorubicin—testicular cancer	0.0359	0.0405	CbGbCtD
Dronabinol—ABCG2—Methotrexate—testicular cancer	0.0348	0.0392	CbGbCtD
Dronabinol—ABCB1—Dactinomycin—testicular cancer	0.0337	0.038	CbGbCtD
Dronabinol—CYP3A4—Ifosfamide—testicular cancer	0.0238	0.0269	CbGbCtD
Dronabinol—ABCB1—Vinblastine—testicular cancer	0.0211	0.0238	CbGbCtD
Dronabinol—CYP2C9—Cisplatin—testicular cancer	0.0199	0.0225	CbGbCtD
Dronabinol—ABCB1—Cisplatin—testicular cancer	0.0193	0.0218	CbGbCtD
Dronabinol—ABCB1—Etoposide—testicular cancer	0.019	0.0214	CbGbCtD
Dronabinol—ABCB1—Doxorubicin—testicular cancer	0.013	0.0146	CbGbCtD
Dronabinol—CYP3A4—Vinblastine—testicular cancer	0.0126	0.0142	CbGbCtD
Dronabinol—ABCB1—Methotrexate—testicular cancer	0.0125	0.0142	CbGbCtD
Dronabinol—CYP3A4—Etoposide—testicular cancer	0.0114	0.0128	CbGbCtD
Dronabinol—CYP3A4—Doxorubicin—testicular cancer	0.00776	0.00875	CbGbCtD
Dronabinol—Ill-defined disorder—Dactinomycin—testicular cancer	0.000588	0.00519	CcSEcCtD
Dronabinol—Gastrointestinal pain—Chlorambucil—testicular cancer	0.000586	0.00517	CcSEcCtD
Dronabinol—Myalgia—Bleomycin—testicular cancer	0.000578	0.00511	CcSEcCtD
Dronabinol—Discomfort—Bleomycin—testicular cancer	0.000571	0.00505	CcSEcCtD
Dronabinol—Malaise—Dactinomycin—testicular cancer	0.000571	0.00505	CcSEcCtD
Dronabinol—Decreased appetite—Vinblastine—testicular cancer	0.000571	0.00504	CcSEcCtD
Dronabinol—Abdominal pain—Chlorambucil—testicular cancer	0.000566	0.005	CcSEcCtD
Dronabinol—Confusional state—Bleomycin—testicular cancer	0.000559	0.00494	CcSEcCtD
Dronabinol—Feeling abnormal—Vinblastine—testicular cancer	0.000541	0.00478	CcSEcCtD
Dronabinol—Myalgia—Dactinomycin—testicular cancer	0.000539	0.00476	CcSEcCtD
Dronabinol—Ill-defined disorder—Ifosfamide—testicular cancer	0.000539	0.00476	CcSEcCtD
Dronabinol—Gastrointestinal pain—Vinblastine—testicular cancer	0.000537	0.00474	CcSEcCtD
Dronabinol—Tinnitus—Cisplatin—testicular cancer	0.000536	0.00473	CcSEcCtD
Dronabinol—Flushing—Cisplatin—testicular cancer	0.000534	0.00471	CcSEcCtD
Dronabinol—Discomfort—Dactinomycin—testicular cancer	0.000533	0.00471	CcSEcCtD
Dronabinol—Anorexia—Bleomycin—testicular cancer	0.000528	0.00467	CcSEcCtD
Dronabinol—Hypersensitivity—Chlorambucil—testicular cancer	0.000528	0.00466	CcSEcCtD
Dronabinol—Malaise—Ifosfamide—testicular cancer	0.000524	0.00462	CcSEcCtD
Dronabinol—Immune system disorder—Cisplatin—testicular cancer	0.000519	0.00459	CcSEcCtD
Dronabinol—Abdominal pain—Vinblastine—testicular cancer	0.000519	0.00458	CcSEcCtD
Dronabinol—Hypotension—Bleomycin—testicular cancer	0.000518	0.00458	CcSEcCtD
Dronabinol—Asthenia—Chlorambucil—testicular cancer	0.000514	0.00454	CcSEcCtD
Dronabinol—Palpitations—Ifosfamide—testicular cancer	0.000513	0.00453	CcSEcCtD
Dronabinol—Mental disability—Epirubicin—testicular cancer	0.00051	0.00451	CcSEcCtD
Dronabinol—Pruritus—Chlorambucil—testicular cancer	0.000507	0.00448	CcSEcCtD
Dronabinol—Cough—Ifosfamide—testicular cancer	0.000507	0.00447	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.000505	0.00446	CcSEcCtD
Dronabinol—Convulsion—Ifosfamide—testicular cancer	0.000503	0.00444	CcSEcCtD
Dronabinol—Myalgia—Ifosfamide—testicular cancer	0.000494	0.00437	CcSEcCtD
Dronabinol—Anorexia—Dactinomycin—testicular cancer	0.000493	0.00435	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.000491	0.00434	CcSEcCtD
Dronabinol—Diarrhoea—Chlorambucil—testicular cancer	0.00049	0.00433	CcSEcCtD
Dronabinol—Flushing—Etoposide—testicular cancer	0.000489	0.00432	CcSEcCtD
Dronabinol—Discomfort—Ifosfamide—testicular cancer	0.000488	0.00431	CcSEcCtD
Dronabinol—Hypersensitivity—Vinblastine—testicular cancer	0.000484	0.00427	CcSEcCtD
Dronabinol—Decreased appetite—Bleomycin—testicular cancer	0.000482	0.00426	CcSEcCtD
Dronabinol—Confusional state—Ifosfamide—testicular cancer	0.000478	0.00422	CcSEcCtD
Dronabinol—Immune system disorder—Etoposide—testicular cancer	0.000476	0.0042	CcSEcCtD
Dronabinol—Chills—Etoposide—testicular cancer	0.000473	0.00417	CcSEcCtD
Dronabinol—Mental disability—Doxorubicin—testicular cancer	0.000472	0.00417	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.000471	0.00416	CcSEcCtD
Dronabinol—Asthenia—Vinblastine—testicular cancer	0.000471	0.00416	CcSEcCtD
Dronabinol—Nervous system disorder—Ifosfamide—testicular cancer	0.000465	0.0041	CcSEcCtD
Dronabinol—Ill-defined disorder—Cisplatin—testicular cancer	0.000464	0.0041	CcSEcCtD
Dronabinol—Skin disorder—Ifosfamide—testicular cancer	0.00046	0.00406	CcSEcCtD
Dronabinol—Hyperhidrosis—Ifosfamide—testicular cancer	0.000458	0.00405	CcSEcCtD
Dronabinol—Feeling abnormal—Bleomycin—testicular cancer	0.000457	0.00404	CcSEcCtD
Dronabinol—Anorexia—Ifosfamide—testicular cancer	0.000452	0.00399	CcSEcCtD
Dronabinol—Malaise—Cisplatin—testicular cancer	0.000451	0.00399	CcSEcCtD
Dronabinol—Decreased appetite—Dactinomycin—testicular cancer	0.000449	0.00397	CcSEcCtD
Dronabinol—Diarrhoea—Vinblastine—testicular cancer	0.000449	0.00397	CcSEcCtD
Dronabinol—Fatigue—Dactinomycin—testicular cancer	0.000446	0.00394	CcSEcCtD
Dronabinol—Hypotension—Ifosfamide—testicular cancer	0.000443	0.00391	CcSEcCtD
Dronabinol—Dizziness—Vinblastine—testicular cancer	0.000434	0.00383	CcSEcCtD
Dronabinol—Convulsion—Cisplatin—testicular cancer	0.000434	0.00383	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000432	0.00381	CcSEcCtD
Dronabinol—Ataxia—Methotrexate—testicular cancer	0.000429	0.00379	CcSEcCtD
Dronabinol—Myalgia—Cisplatin—testicular cancer	0.000426	0.00376	CcSEcCtD
Dronabinol—Feeling abnormal—Dactinomycin—testicular cancer	0.000426	0.00376	CcSEcCtD
Dronabinol—Ill-defined disorder—Etoposide—testicular cancer	0.000425	0.00376	CcSEcCtD
Dronabinol—Anxiety—Cisplatin—testicular cancer	0.000425	0.00375	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000423	0.00374	CcSEcCtD
Dronabinol—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000423	0.00373	CcSEcCtD
Dronabinol—Somnolence—Ifosfamide—testicular cancer	0.000421	0.00372	CcSEcCtD
Dronabinol—Discomfort—Cisplatin—testicular cancer	0.000421	0.00372	CcSEcCtD
Dronabinol—Malaise—Etoposide—testicular cancer	0.000414	0.00365	CcSEcCtD
Dronabinol—Decreased appetite—Ifosfamide—testicular cancer	0.000412	0.00364	CcSEcCtD
Dronabinol—Headache—Vinblastine—testicular cancer	0.000411	0.00363	CcSEcCtD
Dronabinol—Abdominal pain—Dactinomycin—testicular cancer	0.000409	0.00361	CcSEcCtD
Dronabinol—Fatigue—Ifosfamide—testicular cancer	0.000409	0.00361	CcSEcCtD
Dronabinol—Hypersensitivity—Bleomycin—testicular cancer	0.000408	0.00361	CcSEcCtD
Dronabinol—Ataxia—Epirubicin—testicular cancer	0.000401	0.00354	CcSEcCtD
Dronabinol—Nervous system disorder—Cisplatin—testicular cancer	0.000401	0.00354	CcSEcCtD
Dronabinol—Cough—Etoposide—testicular cancer	0.0004	0.00353	CcSEcCtD
Dronabinol—Tachycardia—Cisplatin—testicular cancer	0.000399	0.00352	CcSEcCtD
Dronabinol—Asthenia—Bleomycin—testicular cancer	0.000398	0.00351	CcSEcCtD
Dronabinol—Convulsion—Etoposide—testicular cancer	0.000397	0.00351	CcSEcCtD
Dronabinol—Skin disorder—Cisplatin—testicular cancer	0.000397	0.0035	CcSEcCtD
Dronabinol—Hyperhidrosis—Cisplatin—testicular cancer	0.000395	0.00349	CcSEcCtD
Dronabinol—Pruritus—Bleomycin—testicular cancer	0.000392	0.00346	CcSEcCtD
Dronabinol—Feeling abnormal—Ifosfamide—testicular cancer	0.00039	0.00345	CcSEcCtD
Dronabinol—Anorexia—Cisplatin—testicular cancer	0.000389	0.00344	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000388	0.00342	CcSEcCtD
Dronabinol—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000387	0.00342	CcSEcCtD
Dronabinol—Discomfort—Etoposide—testicular cancer	0.000386	0.00341	CcSEcCtD
Dronabinol—Hypotension—Cisplatin—testicular cancer	0.000382	0.00337	CcSEcCtD
Dronabinol—Hypersensitivity—Dactinomycin—testicular cancer	0.000381	0.00336	CcSEcCtD
Dronabinol—Confusional state—Etoposide—testicular cancer	0.000377	0.00333	CcSEcCtD
Dronabinol—Abdominal pain—Ifosfamide—testicular cancer	0.000375	0.00331	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000372	0.00329	CcSEcCtD
Dronabinol—Ataxia—Doxorubicin—testicular cancer	0.000371	0.00328	CcSEcCtD
Dronabinol—Asthenia—Dactinomycin—testicular cancer	0.000371	0.00328	CcSEcCtD
Dronabinol—Tachycardia—Etoposide—testicular cancer	0.000365	0.00323	CcSEcCtD
Dronabinol—Skin disorder—Etoposide—testicular cancer	0.000363	0.00321	CcSEcCtD
Dronabinol—Hyperhidrosis—Etoposide—testicular cancer	0.000362	0.0032	CcSEcCtD
Dronabinol—Anorexia—Etoposide—testicular cancer	0.000357	0.00315	CcSEcCtD
Dronabinol—Decreased appetite—Cisplatin—testicular cancer	0.000355	0.00314	CcSEcCtD
Dronabinol—Diarrhoea—Dactinomycin—testicular cancer	0.000354	0.00312	CcSEcCtD
Dronabinol—Drowsiness—Methotrexate—testicular cancer	0.000351	0.0031	CcSEcCtD
Dronabinol—Depression—Methotrexate—testicular cancer	0.00035	0.0031	CcSEcCtD
Dronabinol—Hypotension—Etoposide—testicular cancer	0.00035	0.00309	CcSEcCtD
Dronabinol—Rash—Bleomycin—testicular cancer	0.00035	0.00309	CcSEcCtD
Dronabinol—Dermatitis—Bleomycin—testicular cancer	0.000349	0.00308	CcSEcCtD
Dronabinol—Hypersensitivity—Ifosfamide—testicular cancer	0.000349	0.00308	CcSEcCtD
Dronabinol—Conjunctivitis—Methotrexate—testicular cancer	0.000342	0.00302	CcSEcCtD
Dronabinol—Asthenia—Ifosfamide—testicular cancer	0.00034	0.003	CcSEcCtD
Dronabinol—Sweating—Methotrexate—testicular cancer	0.000337	0.00298	CcSEcCtD
Dronabinol—Feeling abnormal—Cisplatin—testicular cancer	0.000337	0.00297	CcSEcCtD
Dronabinol—Pruritus—Ifosfamide—testicular cancer	0.000335	0.00296	CcSEcCtD
Dronabinol—Somnolence—Etoposide—testicular cancer	0.000333	0.00294	CcSEcCtD
Dronabinol—Drowsiness—Epirubicin—testicular cancer	0.000329	0.00291	CcSEcCtD
Dronabinol—Rash—Dactinomycin—testicular cancer	0.000326	0.00288	CcSEcCtD
Dronabinol—Decreased appetite—Etoposide—testicular cancer	0.000325	0.00287	CcSEcCtD
Dronabinol—Diarrhoea—Ifosfamide—testicular cancer	0.000324	0.00286	CcSEcCtD
Dronabinol—Fatigue—Etoposide—testicular cancer	0.000323	0.00285	CcSEcCtD
Dronabinol—Conjunctivitis—Epirubicin—testicular cancer	0.00032	0.00282	CcSEcCtD
Dronabinol—Sweating—Epirubicin—testicular cancer	0.000315	0.00279	CcSEcCtD
Dronabinol—Dizziness—Ifosfamide—testicular cancer	0.000313	0.00277	CcSEcCtD
Dronabinol—Sinusitis—Epirubicin—testicular cancer	0.000309	0.00273	CcSEcCtD
Dronabinol—Feeling abnormal—Etoposide—testicular cancer	0.000308	0.00272	CcSEcCtD
Dronabinol—Gastrointestinal pain—Etoposide—testicular cancer	0.000306	0.0027	CcSEcCtD
Dronabinol—Drowsiness—Doxorubicin—testicular cancer	0.000304	0.00269	CcSEcCtD
Dronabinol—Hypersensitivity—Cisplatin—testicular cancer	0.000301	0.00266	CcSEcCtD
Dronabinol—Rash—Ifosfamide—testicular cancer	0.000299	0.00264	CcSEcCtD
Dronabinol—Dermatitis—Ifosfamide—testicular cancer	0.000298	0.00264	CcSEcCtD
Dronabinol—Rhinitis—Epirubicin—testicular cancer	0.000296	0.00261	CcSEcCtD
Dronabinol—Abdominal pain—Etoposide—testicular cancer	0.000296	0.00261	CcSEcCtD
Dronabinol—Conjunctivitis—Doxorubicin—testicular cancer	0.000296	0.00261	CcSEcCtD
Dronabinol—Tinnitus—Methotrexate—testicular cancer	0.000294	0.0026	CcSEcCtD
Dronabinol—Asthenia—Cisplatin—testicular cancer	0.000293	0.00259	CcSEcCtD
Dronabinol—Sweating—Doxorubicin—testicular cancer	0.000292	0.00258	CcSEcCtD
Dronabinol—Sinusitis—Doxorubicin—testicular cancer	0.000286	0.00252	CcSEcCtD
Dronabinol—Immune system disorder—Methotrexate—testicular cancer	0.000285	0.00252	CcSEcCtD
Dronabinol—Chills—Methotrexate—testicular cancer	0.000283	0.0025	CcSEcCtD
Dronabinol—Diarrhoea—Cisplatin—testicular cancer	0.000279	0.00247	CcSEcCtD
Dronabinol—Hypersensitivity—Etoposide—testicular cancer	0.000276	0.00244	CcSEcCtD
Dronabinol—Tinnitus—Epirubicin—testicular cancer	0.000275	0.00243	CcSEcCtD
Dronabinol—Flushing—Epirubicin—testicular cancer	0.000274	0.00242	CcSEcCtD
Dronabinol—Rhinitis—Doxorubicin—testicular cancer	0.000274	0.00242	CcSEcCtD
Dronabinol—Asthenia—Etoposide—testicular cancer	0.000268	0.00237	CcSEcCtD
Dronabinol—Immune system disorder—Epirubicin—testicular cancer	0.000267	0.00236	CcSEcCtD
Dronabinol—Chills—Epirubicin—testicular cancer	0.000265	0.00234	CcSEcCtD
Dronabinol—Pruritus—Etoposide—testicular cancer	0.000265	0.00234	CcSEcCtD
Dronabinol—Rash—Cisplatin—testicular cancer	0.000258	0.00227	CcSEcCtD
Dronabinol—Dermatitis—Cisplatin—testicular cancer	0.000257	0.00227	CcSEcCtD
Dronabinol—Diarrhoea—Etoposide—testicular cancer	0.000256	0.00226	CcSEcCtD
Dronabinol—Ill-defined disorder—Methotrexate—testicular cancer	0.000255	0.00225	CcSEcCtD
Dronabinol—Tinnitus—Doxorubicin—testicular cancer	0.000255	0.00225	CcSEcCtD
Dronabinol—Flushing—Doxorubicin—testicular cancer	0.000254	0.00224	CcSEcCtD
Dronabinol—Tension—Epirubicin—testicular cancer	0.000252	0.00223	CcSEcCtD
Dronabinol—Nervousness—Epirubicin—testicular cancer	0.00025	0.0022	CcSEcCtD
Dronabinol—Malaise—Methotrexate—testicular cancer	0.000248	0.00219	CcSEcCtD
Dronabinol—Dizziness—Etoposide—testicular cancer	0.000247	0.00219	CcSEcCtD
Dronabinol—Immune system disorder—Doxorubicin—testicular cancer	0.000247	0.00218	CcSEcCtD
Dronabinol—Chills—Doxorubicin—testicular cancer	0.000245	0.00217	CcSEcCtD
Dronabinol—Cough—Methotrexate—testicular cancer	0.00024	0.00212	CcSEcCtD
Dronabinol—Ill-defined disorder—Epirubicin—testicular cancer	0.000238	0.00211	CcSEcCtD
Dronabinol—Convulsion—Methotrexate—testicular cancer	0.000238	0.0021	CcSEcCtD
Dronabinol—Rash—Etoposide—testicular cancer	0.000236	0.00208	CcSEcCtD
Dronabinol—Dermatitis—Etoposide—testicular cancer	0.000236	0.00208	CcSEcCtD
Dronabinol—Headache—Etoposide—testicular cancer	0.000234	0.00207	CcSEcCtD
Dronabinol—Myalgia—Methotrexate—testicular cancer	0.000234	0.00207	CcSEcCtD
Dronabinol—Tension—Doxorubicin—testicular cancer	0.000233	0.00206	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000232	0.00205	CcSEcCtD
Dronabinol—Malaise—Epirubicin—testicular cancer	0.000232	0.00205	CcSEcCtD
Dronabinol—Discomfort—Methotrexate—testicular cancer	0.000231	0.00204	CcSEcCtD
Dronabinol—Nervousness—Doxorubicin—testicular cancer	0.000231	0.00204	CcSEcCtD
Dronabinol—Palpitations—Epirubicin—testicular cancer	0.000227	0.00201	CcSEcCtD
Dronabinol—Confusional state—Methotrexate—testicular cancer	0.000226	0.002	CcSEcCtD
Dronabinol—Cough—Epirubicin—testicular cancer	0.000224	0.00198	CcSEcCtD
Dronabinol—Convulsion—Epirubicin—testicular cancer	0.000223	0.00197	CcSEcCtD
Dronabinol—Ill-defined disorder—Doxorubicin—testicular cancer	0.000221	0.00195	CcSEcCtD
Dronabinol—Nervous system disorder—Methotrexate—testicular cancer	0.00022	0.00194	CcSEcCtD
Dronabinol—Myalgia—Epirubicin—testicular cancer	0.000219	0.00193	CcSEcCtD
Dronabinol—Anxiety—Epirubicin—testicular cancer	0.000218	0.00193	CcSEcCtD
Dronabinol—Skin disorder—Methotrexate—testicular cancer	0.000218	0.00192	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000217	0.00192	CcSEcCtD
Dronabinol—Hyperhidrosis—Methotrexate—testicular cancer	0.000217	0.00191	CcSEcCtD
Dronabinol—Discomfort—Epirubicin—testicular cancer	0.000216	0.00191	CcSEcCtD
Dronabinol—Malaise—Doxorubicin—testicular cancer	0.000214	0.00189	CcSEcCtD
Dronabinol—Dry mouth—Epirubicin—testicular cancer	0.000214	0.00189	CcSEcCtD
Dronabinol—Anorexia—Methotrexate—testicular cancer	0.000214	0.00189	CcSEcCtD
Dronabinol—Confusional state—Epirubicin—testicular cancer	0.000212	0.00187	CcSEcCtD
Dronabinol—Palpitations—Doxorubicin—testicular cancer	0.00021	0.00186	CcSEcCtD
Dronabinol—Hypotension—Methotrexate—testicular cancer	0.000209	0.00185	CcSEcCtD
Dronabinol—Cough—Doxorubicin—testicular cancer	0.000208	0.00183	CcSEcCtD
Dronabinol—Convulsion—Doxorubicin—testicular cancer	0.000206	0.00182	CcSEcCtD
Dronabinol—Nervous system disorder—Epirubicin—testicular cancer	0.000206	0.00182	CcSEcCtD
Dronabinol—Tachycardia—Epirubicin—testicular cancer	0.000205	0.00181	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000204	0.0018	CcSEcCtD
Dronabinol—Skin disorder—Epirubicin—testicular cancer	0.000204	0.0018	CcSEcCtD
Dronabinol—Hyperhidrosis—Epirubicin—testicular cancer	0.000203	0.00179	CcSEcCtD
Dronabinol—Myalgia—Doxorubicin—testicular cancer	0.000202	0.00179	CcSEcCtD
Dronabinol—Anxiety—Doxorubicin—testicular cancer	0.000202	0.00178	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000201	0.00178	CcSEcCtD
Dronabinol—Discomfort—Doxorubicin—testicular cancer	0.0002	0.00177	CcSEcCtD
Dronabinol—Anorexia—Epirubicin—testicular cancer	0.0002	0.00177	CcSEcCtD
Dronabinol—Somnolence—Methotrexate—testicular cancer	0.000199	0.00176	CcSEcCtD
Dronabinol—Dry mouth—Doxorubicin—testicular cancer	0.000198	0.00175	CcSEcCtD
Dronabinol—Hypotension—Epirubicin—testicular cancer	0.000196	0.00173	CcSEcCtD
Dronabinol—Confusional state—Doxorubicin—testicular cancer	0.000196	0.00173	CcSEcCtD
Dronabinol—Decreased appetite—Methotrexate—testicular cancer	0.000195	0.00172	CcSEcCtD
Dronabinol—Fatigue—Methotrexate—testicular cancer	0.000193	0.00171	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000191	0.00169	CcSEcCtD
Dronabinol—Nervous system disorder—Doxorubicin—testicular cancer	0.00019	0.00168	CcSEcCtD
Dronabinol—Tachycardia—Doxorubicin—testicular cancer	0.000189	0.00167	CcSEcCtD
Dronabinol—Skin disorder—Doxorubicin—testicular cancer	0.000189	0.00167	CcSEcCtD
Dronabinol—Hyperhidrosis—Doxorubicin—testicular cancer	0.000188	0.00166	CcSEcCtD
Dronabinol—Somnolence—Epirubicin—testicular cancer	0.000186	0.00165	CcSEcCtD
Dronabinol—Anorexia—Doxorubicin—testicular cancer	0.000185	0.00163	CcSEcCtD
Dronabinol—Feeling abnormal—Methotrexate—testicular cancer	0.000185	0.00163	CcSEcCtD
Dronabinol—Gastrointestinal pain—Methotrexate—testicular cancer	0.000183	0.00162	CcSEcCtD
Dronabinol—Decreased appetite—Epirubicin—testicular cancer	0.000182	0.00161	CcSEcCtD
Dronabinol—Hypotension—Doxorubicin—testicular cancer	0.000181	0.0016	CcSEcCtD
Dronabinol—Fatigue—Epirubicin—testicular cancer	0.000181	0.0016	CcSEcCtD
Dronabinol—Abdominal pain—Methotrexate—testicular cancer	0.000177	0.00157	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000177	0.00156	CcSEcCtD
Dronabinol—Feeling abnormal—Epirubicin—testicular cancer	0.000173	0.00153	CcSEcCtD
Dronabinol—Somnolence—Doxorubicin—testicular cancer	0.000173	0.00152	CcSEcCtD
Dronabinol—Gastrointestinal pain—Epirubicin—testicular cancer	0.000172	0.00152	CcSEcCtD
Dronabinol—Decreased appetite—Doxorubicin—testicular cancer	0.000169	0.00149	CcSEcCtD
Dronabinol—Fatigue—Doxorubicin—testicular cancer	0.000167	0.00148	CcSEcCtD
Dronabinol—Abdominal pain—Epirubicin—testicular cancer	0.000166	0.00146	CcSEcCtD
Dronabinol—Hypersensitivity—Methotrexate—testicular cancer	0.000165	0.00146	CcSEcCtD
Dronabinol—Asthenia—Methotrexate—testicular cancer	0.000161	0.00142	CcSEcCtD
Dronabinol—Feeling abnormal—Doxorubicin—testicular cancer	0.00016	0.00141	CcSEcCtD
Dronabinol—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000159	0.0014	CcSEcCtD
Dronabinol—Pruritus—Methotrexate—testicular cancer	0.000159	0.0014	CcSEcCtD
Dronabinol—Hypersensitivity—Epirubicin—testicular cancer	0.000155	0.00137	CcSEcCtD
Dronabinol—Abdominal pain—Doxorubicin—testicular cancer	0.000153	0.00136	CcSEcCtD
Dronabinol—Diarrhoea—Methotrexate—testicular cancer	0.000153	0.00135	CcSEcCtD
Dronabinol—Asthenia—Epirubicin—testicular cancer	0.000151	0.00133	CcSEcCtD
Dronabinol—Pruritus—Epirubicin—testicular cancer	0.000148	0.00131	CcSEcCtD
Dronabinol—Dizziness—Methotrexate—testicular cancer	0.000148	0.00131	CcSEcCtD
Dronabinol—Diarrhoea—Epirubicin—testicular cancer	0.000144	0.00127	CcSEcCtD
Dronabinol—Hypersensitivity—Doxorubicin—testicular cancer	0.000143	0.00126	CcSEcCtD
Dronabinol—Rash—Methotrexate—testicular cancer	0.000141	0.00125	CcSEcCtD
Dronabinol—Dermatitis—Methotrexate—testicular cancer	0.000141	0.00125	CcSEcCtD
Dronabinol—Headache—Methotrexate—testicular cancer	0.00014	0.00124	CcSEcCtD
Dronabinol—Asthenia—Doxorubicin—testicular cancer	0.000139	0.00123	CcSEcCtD
Dronabinol—Dizziness—Epirubicin—testicular cancer	0.000139	0.00123	CcSEcCtD
Dronabinol—Pruritus—Doxorubicin—testicular cancer	0.000137	0.00121	CcSEcCtD
Dronabinol—Diarrhoea—Doxorubicin—testicular cancer	0.000133	0.00117	CcSEcCtD
Dronabinol—Rash—Epirubicin—testicular cancer	0.000132	0.00117	CcSEcCtD
Dronabinol—Dermatitis—Epirubicin—testicular cancer	0.000132	0.00117	CcSEcCtD
Dronabinol—Headache—Epirubicin—testicular cancer	0.000131	0.00116	CcSEcCtD
Dronabinol—Dizziness—Doxorubicin—testicular cancer	0.000128	0.00113	CcSEcCtD
Dronabinol—Rash—Doxorubicin—testicular cancer	0.000122	0.00108	CcSEcCtD
Dronabinol—Dermatitis—Doxorubicin—testicular cancer	0.000122	0.00108	CcSEcCtD
Dronabinol—Headache—Doxorubicin—testicular cancer	0.000122	0.00107	CcSEcCtD
